Skip to content

Dr Oleg Melnyk CV

+33 (0)3 20 87 12 14

Date of birth: 03/27/1966; Nationality: French 

Researcher unique identifier: ORCID 0000-0002-3863-5613

Contribution to synthetic organic chemistry: I pioneered the development of reversible amides acting as acyl donors in water and enabling the total chemical synthesis of proteins under redox control (Chem. Rev. 2019 DOI, Curr. Opin. Chem. Biol. 2020 DOI, Acc. Chem. Res. 2022 DOI, co-foundation of XProChem).

Contribution to chemical biology & protein therapeutic design: I contributed to the understanding of hepatocyte growth factor/MET receptor activation determinants using chemical biology approaches. This knowledge enabled the design of a strong MET agonist currently developed for regenerative medicine, in collaboration with E. Gherardi’s team in Pavia, Italy (Chem. Sci. 2015 DOI, Life Sci. Alliance 2022 DOI)

Contribution to micro-nanotechnologies: I contributed to the development of ligation chemistries enabling the synthesis of conjugates, the attachment of peptides to surfaces and the design of peptide/protein-based micro-nanosystems (Bioconjugate Chem. 2004 DOI, Appl. Phys. Lett. 2004 DOI, co-foundation of Innobiochips)

EDUCATION

2000      Habilitation thesis to supervise research.

1994      PhD “Total synthesis of cortisone”. University Pierre et Marie Curie, Paris, France.

1989      Master « Organocuprate chemistry ». University Pierre et Marie Curie, Paris, France.

1989      Engineer from Ecole Nationale Supérieure de Chimie de Paris, France.


CURRENT POSITION

Since 2006. Director of Research at CNRS working as team leader.


PREVIOUS POSITIONS

2002-2006           Team leader, Pasteur Institute of Lille, France

1996-2002         CNRS researcher, Pasteur Institute of Lille, France

1994-1996         Post-doc “Design of b-turn mimetics”, Pasteur Institute of Lille, France

1990-1994           PhD at Roussel-Uclaf (now Sanofi), Romainville, France

1989-1990           Engineer at the Central Commission of Nuclear Energy (CEA), Bruyère-le-Chatel, France.


FELLOWSHIPS AND AWARDS

2014                     Grand Valorization Prize received from the Société Industrielle du Nord de France (SINF)

2013                      Innovation trophy from Institut National de la Propriété Industrielle (INPI)


CREATION OF START-UPS

2012      Co-founder of XProChem. http://xprochem.com/fr/

2008      Co-founder of Innobiochips. http://www.innobiochips.fr/


MEMBERSHIPS OF SCIENTIFIC SOCIETIES

Since 2021          Board member of the European Peptide Society (French representative)

Since 2021          Board member of the French peptide & protein society (GFPP)


PARTICIPATION TO EDITORIAL BOARDS

Since 2022         Biopolymers

Since 2013          International Journal of Peptide Therapeutics


SELECTION OF FIVE RECENT PUBLICATIONS

1Desmet, R., Boidin-Wichlacz, C., Mhidia, R., Tasiemski, A., Agouridas, V., and Melnyk, O. (2023). An Iron-Catalyzed Protein Desulfurization Method Reminiscent of Aquatic Chemistry. Angew. Chem. Int. Ed. 62. e202302648. DOI A novel method for effecting the selective desulfurization of cysteine at the protein level, using an iron-catalyzed process reminiscent of aquatic chemistry. Hot Paper.
2Ollivier, N., Sénéchal, M., Desmet, R., Snella, B., Agouridas, V., and Melnyk, O. (2022). A biomimetic electrostatic assistance for guiding and promoting N-terminal protein chemical modification. Nat. Commun. 13. 66667. DOI We achieved outstanding accelerations for peptide bond formation by engineering electrostatic interactions in the peptide reactants.
3Snella, B.; Grain, B.; Vicogne, J.; Capet, F.; Melnyk, O.; Agouridas, V. (2022) Fast protein modification in the nanomolar concentration range using an oxalyl amide as latent thioester. Angew. Chem. Int. Ed. 61, e202204992. DOI Inspired by the very high reactivity of some cell metabolites, this work has potentially significant implications for the accelerated production of conjugates of medical interest. Hot Paper.
4Agouridas, V.; Ollivier, N.; Vicogne, J.; Diemer, V.; Melnyk, O.c Redox-controlled chemical protein synthesis: sundry shades of latency. Acc. Chem. Res. 2022, 55, 2685-2697. DOI An account of our work on the chemical synthesis of proteins using redox controlled chemical systems.  
5Diemer, V.; Ollivier, N.; Leclercq, B.; Drobecq, H.; Vicogne, J.; Agouridas, V.; Melnyk, O. (2020) A cysteine selenosulfide redox switch for protein chemical synthesis. Nat. Commun. 11, 2558. DOIWe designed a redox-controlled cysteine surrogate facilitating the chemical synthesis of complex protein scaffolds such as cyclic proteins. Article highlighted by the Editors of Nature Communications.